Illinois SB3509 mandates coverage for biomarker testing in health insurance policies, ensuring transparency and accessibility.

Illinois SB3509 amends the Illinois Insurance Code to require coverage for biomarker testing in health insurance policies. This includes single-analyte tests, multi-plex panel tests, and whole genome sequencing. The bill mandates that insurers provide clear justifications for any denials of coverage supported by specified evidence. It also requires insurers to update and publicly disclose medical policies and coverage guidelines within 90 days of the bill's effective date. The Department of Insurance is authorized to conduct periodic audits and reviews to ensure compliance.

Illinois SB3509 mandates coverage for biomarker testing in health insurance policies, ensuring transparency and accessibility.

Illinois SB3509 amends the Illinois Insurance Code to require coverage for biomarker testing in health insurance policies. This includes single-analyte tests, multi-plex panel tests, and whole genome sequencing. The bill mandates that insurers provide clear justifications for any denials of coverage supported by specified evidence. It also requires insurers to update and publicly disclose medical policies and coverage guidelines within 90 days of the bill's effective date. The Department of Insurance is authorized to conduct periodic audits and reviews to ensure compliance.